CYP cynata therapeutics limited

Ann: Cynata Adds New Sites for DFU Clinical Trial, page-30

  1. 16,301 Posts.
    lightbulb Created with Sketch. 6210
    Certainly a lot going on in the diabetic wound healing arena, which also means more competition for CYP as it tackles DFU's .... interesting read for those interested


    In vivo, dual-crosslinked hydrogels contributed to faster diabetic #WoundHealing than PRP and SP by upregulating growth factor expression, down-regulating matrix metalloproteinase-9 expression, and by promoting an anti-NETotic effect.







    https://www.sciencedirect.com/science/article/pii/S2452199X23001469?via=ihub

    Engineering homologous platelet-rich plasma, platelet-rich plasma-derived exosomes, and mesenchymal stem cell-derived exosomes-based dual-crosslinked hydrogels as bioactive diabetic wound dressings
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.